Proton pump inhibitor and community pharmacies: Usage profile and factors associated with long-term use.
<h4>Aim</h4>To characterize the usage profile and the factors associated with the prolonged use of proton pump inhibitor drugs in a community pharmacy.<h4>Methodology</h4>This is a cross-sectional, prospective and observational study involving interviews with 410 patients who...
Enregistré dans:
Auteurs principaux: | Lorena Maria Lima de Araújo, Maria Vivyanne de Moura Lopes, Rafael Silva de Arruda, Rand Randall Martins, Antonio Gouveia Oliveira |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/d158349e62ad49f897372c89e2b8b239 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Biomarkers for oralization during long-term proton pump inhibitor therapy predict survival in cirrhosis
par: Angela Horvath, et autres
Publié: (2019) -
The proton-pump inhibitor lansoprazole enhances amyloid beta production.
par: Nahuai Badiola, et autres
Publié: (2013) -
Analysis of the Effect of Proton-Pump Inhibitors on the Course of COVID-19
par: Zhang XY, et autres
Publié: (2021) -
Proton pump inhibitors inhibit metformin uptake by organic cation transporters (OCTs).
par: Anne T Nies, et autres
Publié: (2011) -
Delirium in the geriatric unit: proton-pump inhibitors and other risk factors
par: Otremba I, et autres
Publié: (2016)